Sacubitril/Valsartan vs. RAS Inhibition in De Novo Heart Failure

Posted: 2025-04-24 04:54:31 UTC

@European Society of Cardiology JournalsESC_Journals

#HFA_ESC

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Full Thread

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Status

In Progress

VerifiedPartially VerifiedFalse

Last Updated

2025-04-24 04:56:38 UTC

Verified By

Rollup News

A real-world study compares the effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure.

Comparative effectiveness of sacubitril/valsartan vs. RAS inhibition in de novo heart failure patients

Real-world study results